40% Obesity Prevalence, $170B in Costs: The Numbers Every Nutrition Executive Needs to See
Understanding the Epidemiological Shift Driving the Next Decade of Consumer Health Demand
Weight Management
The $100B Weight-Loss Drug Boom Has a Blind Spot — Are You Positioned for It?
Muscle Loss, Regain After Discontinuation, and GI Side Effects Are Driving Demand for Complementary Nutritional Solutions
Beyond GLP-1s and Surgery: The Case for Targeting the Gut Microbiome
Emerging Research Reveals How Dysbiosis Drives Obesity — and Why Probiotic Intervention Could Be the Missing Link
A Probiotic That Absorbs Fat Before You Do
Screened from Over 20,000 Bacterial Strains, JBD Probiotics Intercept Dietary Fat Absorption at the Source
95%+ Survival Through Simulated GI Conditions — By Design, Not by Chance
Full Genomic Safety Screening and Strain-Specific Prebiotic Matching for the JBD Probiotic Family
50% of Dietary Fat, Absorbed Before It Reaches You
In Vitro Data Reveal How Live JBD Bacteria Actively Intercept Fatty Acids — And Why Viability Is Non-Negotiable
Why Formulators Are Watching This Probiotic Closely
Preclinical data show JBD301 rivals a leading pharmaceutical intervention in weight control — with the clean label your customers want.